Search
for

    Sort by

    Research 421–450 of 1000+

    1. Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer Medical Oncology · 2013 · 6 citations
    2. Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient Journal of the European Academy of Dermatology and Venereology · 2018 · 9 citations
    3. Ottawa, Ontario, Canada, February 13–16, 2013 The Journal of Rheumatology · 2013 · 4 citations
    4. Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team International Journal of Clinical Oncology · 2026
    5. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    6. Pigmentary-Hair-Follicle Unit Under Innovative Pathologic Investigation - Is There a Potential to Improve Outcome of Sensor-Controlled Scalp-Cooling? Journal of Oncology Research and Therapy · 2025
    7. Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology American Journal of Clinical Dermatology · 2026
    8. Intracellular Calcium Mobilization in Response to Ion Channel Regulators via a Calcium-Induced Calcium Release Mechanism 2016 · 19 citations
    9. Investigation on antimicrobial, antioxidant, and anti-cancerous activity of Agaricus bisporus derived β-Glucan against cervical cancer cell line Cellular and molecular biology · 2022 · 2 citations
    10. Post-oncologic skin health: cutaneous recovery and rehabilitation after cancer treatments Frontiers in Oncology · 2026
    11. Identification and in silico analysis of phytochemicals from Phyla nodiflora (l.): Potential bioactive compounds for targeted therapy 2024
    12. Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents. Revista chilena de nutrición · 2017 · 3 citations
    13. Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease. BIOMED natural and applied science · 2025 · 3 citations
    14. Integrated edge information and pathway topology for drug-disease associations iScience · 2024
    15. Alopécia Permanente Pós-Quimioterapia com Resposta Favorável ao Minoxidil Tópico Revista da Sociedade Portuguesa de Dermatologia e Venereologia · 2017
    16. Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema Integrative Cancer Therapies · 2016 · 27 citations
    17. Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study Journal of Dermatological Treatment · 2026 · 2 citations
    18. Thiohydrazides in the Synthesis of Functionalized Extranuclear Heterosteroids 2023
    19. Angiosarcoma of the Scalp Mimicking an Inflammatory Scarring Alopecia and Diagnosed on Horizontal Histologic Sections Journal of Cutaneous Pathology · 2024 · 1 citations
    20. Notes from the Editor Emeritus: Finasteride: the downtrodden hero of hair transplantation emerges once again International Society of Hair Restoration Surgery · 2012
    21. Abstract CN06-04: The hedgehog signaling pathway in cancer. Molecular Cancer Therapeutics · 2011
    22. Exploring obesity-related endocrine disorders beyond diabetes: a narrative review The Egyptian Journal of Internal Medicine · 2024 · 4 citations
    23. Diseases of the Canine Prostate Gland Veterinary medicine and science · 2022 · 1 citations
    24. How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss Skin appendage disorders · 2022
    25. Post-Finasteride Syndrome (PFS) Update: Point/Counterpoint Hair transplant forum international · 2016
    26. Non-Contraceptive Benefits of Oral Hormonal Contraceptives 2012 · 83 citations
    27. Estrogenic Potential of 2-Alkyl-4-(thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase Journal of Medicinal Chemistry · 2003 · 37 citations
    28. Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy JNCI Cancer Spectrum · 2019 · 26 citations
    29. Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trial ESMO Open · 2025 · 2 citations
    30. Alarmin Cytokines as Central Regulators of Cutaneous Immunity Frontiers in Immunology · 2022 · 51 citations